371 related articles for article (PubMed ID: 21492631)
1. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.
Pinner NA; Hurdle AC; Oliphant C; Reaves A; Lobo B; Sills A
World Neurosurg; 2010 Dec; 74(6):631-5. PubMed ID: 21492631
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
3. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
[TBL] [Abstract][Full Text] [Related]
4. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
DeLoughery E; Avery B; DeLoughery TG
Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
[TBL] [Abstract][Full Text] [Related]
8. Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage.
DeLoughery EP; DeLoughery TG
Blood Coagul Fibrinolysis; 2017 Dec; 28(8):612-616. PubMed ID: 28654426
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.
Freeman WD; Brott TG; Barrett KM; Castillo PR; Deen HG; Czervionke LF; Meschia JF
Mayo Clin Proc; 2004 Dec; 79(12):1495-500. PubMed ID: 15595332
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a low, fixed dose and a high, weight-based dose of recombinant factor VIIa in the treatment of warfarin-associated intracranial hemorrhage.
Robbins A; Fong J; Hall W; Ditch K; Rolfe S; Miller M
Neurocrit Care; 2014 Jun; 20(3):466-9. PubMed ID: 23595666
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
Kwon JO; MacLaren R
Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
Edavettal M; Rogers A; Rogers F; Horst M; Leng W
Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
[TBL] [Abstract][Full Text] [Related]
13. Reversal strategies and outcomes in patients with atrial fibrillation and warfarin-associated intracranial hemorrhage.
Singer DE; Borowsky LH; Regan S; Lee JW; Zint K; Franca LR; Goldstein JN
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104903. PubMed ID: 32689580
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
Huynh TK; Costello JL; Rebuck JA
Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of Prothrombin Complex Concentrate for Warfarin-related Intracranial Hemorrhage].
Imura J; Yamakawa A; Ikeda M; Morikawa M; Kohmura E
No Shinkei Geka; 2019 Jun; 47(6):629-636. PubMed ID: 31235665
[TBL] [Abstract][Full Text] [Related]
16. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
[TBL] [Abstract][Full Text] [Related]
17. Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage.
Corio JL; Sin JH; Hayes BD; Goldstein JN; Fuh L
West J Emerg Med; 2018 Sep; 19(5):849-854. PubMed ID: 30202498
[TBL] [Abstract][Full Text] [Related]
18. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage.
Rhoney DH; La M; Merz M; Cook A; Owusu KA; Roels C; Blunck J; Shewmaker J; Sangha KS; Farrokh S; Lewin J; Chester KW; Human T; Bledsoe K; Greene K; Levesque M; Rocker JC; Davis G; Neyens R; Lassiter TF; Adriance SM
Neurocrit Care; 2021 Aug; 35(1):130-138. PubMed ID: 33219462
[TBL] [Abstract][Full Text] [Related]
19. Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding.
Voils SA; Martin EJ; Mohammed BM; Bayrlee A; Brophy DF
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):443-7. PubMed ID: 25699612
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa for warfarin-associated intracranial bleeding.
Ilyas C; Beyer GM; Dutton RP; Scalea TM; Hess JR
J Clin Anesth; 2008 Jun; 20(4):276-9. PubMed ID: 18617125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]